Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts

Journal of Cellular Physiology

Volumn 217, Issue 1, 2008, Pages 250-260

  Epting, Conrad L ^a,b   King, Frank W ^a   Pedersen, Anissa ^a   Zaman, Jessica ^a   Ritner, Carissa ^a   Bernstein, Harold S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULINASE; LIPID; MESSENGER RNA; SMALL INTERFERING RNA; STEM CELL ANTIGEN 1; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME INHIBITION; LIPID ANALYSIS; MITOGENICITY; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; STEM CELL; ANIMAL; CELL CULTURE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, LY; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; INSULYSIN; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; MICROSCOPY, CONFOCAL; MYOBLASTS, SKELETAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 49649119961     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21500     Document Type: Article

References (51)

1. Authier F, Posner BI, Bergeron JJ. 1996. Insulin-degrading enzyme. Clin Invest Med 19:149-160.
2. Bamezai A, Rock KL. 1995. Overexpressed Ly-6A.2 mediates cell-cell adhesion by binding a ligand expressed on lymphoid cells. Proc Natl Acad Sci USA 92:4294-4298.
3. Bassel-Duby R, Olson EN. 2006. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75:19-37.
4. Blumenthal R, Clague MJ, Durell SR, Epand RM. 2003. Membrane fusion. Chem Rev 103:53-69.
5. Bohuslav J, Cinek T, Horejsi V. 1993. Large, detergent-resistant complexes containing murine antigens Thy-1 and Ly-6 and protein tyrosine kinase p56lck. Eur J Immunol 23:825-831.
6. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H. 1995. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 181:1381-1390.
7. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. 2007. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317:807-810.
8. Clissold PM. 1994. Recombinant glycosyl-phosphatidylinositol-anchored proteins are not associated with protein kinases in transfected thymoma cells. Biochem J 304:853-559.
9. Dalley JA, Bulleid NJ. 2003. The endoplasmic reticulum (ER) translocon can differentiate between hydrophobic sequences allowing signals for glycosylphosphatidylinositol anchor addition to be fully translocated into the ER lumen. J Biol Chem 278:51749-51757.
10. Duckworth WC, Bennett RG, Hamel FG. 1998. Insulin degradation: Progress and potential. Endocr Rev 19:608-624.
11. Epting CL, Lopez JE, Shen X, Liu L, Bristow J, Bernstein HS. 2004. Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells. J Cell Sci 117:6185-6195.
12. Epting CL, Lopez JE, Pedersen A, Brown C, Spitz P, Ursell PC, Bernstein HS. 2008. Stem cell antigen-1 regulates the tempo of muscle repair through effects on proliferation of alpha7 integrin-expressing myoblasts. Exp Cell Res 314:1125-1135.
13. Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, Norgren S, Luthman H, Galli J. 2000. Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet 9:2149-2158.
14. Foster LJ, Chan QW. 2007. Lipid raft proteomics: More than just detergent-resistant membranes. Subcell Biochem 43:35-47.
15. Goldspink G, Harridge SD. 2004. Growth factors and muscle ageing. Exp Gerontol 39:1433-1438.
16. Harder T, Scheiffele P, Verkade P, Simons K. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141:929-942.
17. Hawke TJ, Garry DJ. 2001. Myogenic satellite cells: Physiology to molecular biology. J Appl Physiol 91:534-551.
18. Hoessli DC, Ilangumaran S, Soltermann A, Robinson PJ, Borisch B, Nasir Ud D. 2000. Signaling through sphingolipid microdomains of the plasma membrane: The concept of signaling platform. Glycoconj J 17:191-197.
19. Holmes C, Stanford WL. 2007. Stem cell antigen-1: Expression, function, and enigma. Stem Cells 25:1339-1347.
20. Ilangumaran S, Hoessli DC. 1998. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J 335:433-440.
21. Im H, Manolopoulou M, Malito E, Shen Y, Zhao J, Neant-Fery M, Sun CY, Meredith SC, Sisodia SS, Leissring MA, Tang WJ. 2007. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem 282:25453-25463.
22. Jensen ON, Wilm M, Shevchenko A, Mann M. 1999. Peptide sequencing of 2-DE gel-isolated proteins by nanoelectrospray tandem mass spectrometry. Methods Mol Biol 112:571-588.
23. Kang Q, Cao Y, Zolkiewska A. 2000. Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem J 352:883-892.
24. Kayalar C, Wong WT. 1989. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. J Biol Chem 264:8928-8934.
25. Kenworthy AK, Petranova N, Edidin M. 2000. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11:1645-1655.
26. Landberg G, Tan EM, Roos G. 1990. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: A new view of the cell cycle. Exp Cell Res 187:111-118.
27. Lee SK, Su B, Maher SE, Bothwell AL. 1994. Ly-6A is required for T cell receptor expression and protein tyrosine kinase fyn activity. EMBO J 13:2167-2176.
28. Li P, Kuo WL, Yousef M, Rosner MR, Tang WJ. 2006. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem Biophys Res Commun 343:1032-1037.
29. Ludolph DC, Konieczny SF. 1995. Transcription factor families: Muscling in on the myogenic program. FASEB J 9:1595-1604.
30. Mitchell PO, Mills T, O'Connor RS, Kline ER, Graubert T, Dzierzak E, Pavlath GK. 2005. Sca-1 negatively regulates proliferation and differentiation of muscle cells. Dev Biol 283:240-252.
31. Morgan DO. 1997. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Ann Rev Cell Dev Biol 13:261-291.
32. Nichols BJ. 2003. GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr Biol 13:686-690.
33. Niemela PS, Ollila S, Hyvonen MT, Karttunen M, Vattulainen I. 2007. Assessing the nature of lipid raft membranes. PLoS Comput Biol 3:e34.
34. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273:32730-32738.
35. Rajendran L, Masilamani M, Solomon S, Tikkanen R, Stuermer CA, Plattner H, Illges H. 2003. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc Natl Acad Sci USA 100:8241-8246.
36. Rosenberg J, Szabo A, Rheuark D, Kayalar C. 1985. Correlation between fusion and the developmental regulation of membrane glycoproteins in L6 myoblasts. Proc Natl Acad Sci USA 82:8409-8413.
37. Salzer U, Prohaska R. 2001. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 97:1141-1143.
38. Seta KA, Roth RA. 1997. Overexpression of insulin degrading enzyme: Cellular localization and effects on insulin signaling. Biochem Biophys Res Commun 231:167-171.
39. Sharrocks AD. 1994. A T7 expression vector for producing N- and C-terminal fusion proteins with glutathione S-transferase. Gene 138:105-108.
40. Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, Bernstein HS. 2003. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226:128-138.
41. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. 2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881- 885.
42. Smythe GM, Eby JC, Disatnik MH, Rando TA. 2003. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. J Cell Sci 116:4739-4749.
43. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160-15165.
44. Spurway TD, Dalley JA, High S, Bulleid NJ. 2001. Early events in glycosylphosphatidylinositol anchor addition, substrate proteins associate with the transamidase subunit gpi8p. J Biol Chem 276:15975-15982.
45. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016-1619.
46. Su B, Waneck GL, Flavell RA, Bothwell AL. 1991. The glycosylphosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation. J Cell Biol 112:377-384.
47. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261.
48. Udrisar DP, Wanderley MI, Porto RC, Cardoso CL, Barbosa MC, Camberos MC, Cresto JC. 2005. Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus. Exp Biol Med 230:479-486.
49. Vyas KA, Patel HV, Vyas AA, Schnaar RL. 2001. Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol Chem 382:241-250.
50. Zhang F, Tom CC, Kugler MC, Ching TT, Kreidberg JA, Wei Y, Chapman HA. 2003. Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol 163:177-188.
51. Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM. 2004. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention. J Neurosci 24:11120-11126.